Final pathology revealed 5.5 cm tumor containing grade 2 invasive lobular carcinoma that was estrogen receptor (ER) and progesterone receptor (PR) positive, and Her2/neu negative. The gene discussed is ESR1; the disease is invasive lobular breast carcinoma.